Cyclin D1 antibody (C-Term)

Catalog No. ABIN1881175

This Rabbit Polyclonal antibody specifically detects Cyclin D1 in WB. It exhibits reactivity toward Human and has been mentioned in 6+ publications.

Quick Overview for Cyclin D1 antibody (C-Term) (ABIN1881175)

Target: Cyclin D1 (CCND1)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Cyclin D1 antibody is un-conjugated

Application: Western Blotting (WB)

Clone: RB42158

Product Details anti-Cyclin D1 Antibody

Binding Specificity: AA 267-294, C-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This CCND1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 267-294 amino acids from the C-terminal region of human CCND1.

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Expiry Date: 6 months

References for anti-Cyclin D1 antibody (ABIN1881175)

Yang, Wei, Wang, Shen, Xu, Cao: "TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway." in: International journal of clinical and experimental pathology, Vol. 8, Issue 9, pp. 11837-46, (2016) (PubMed).

Aggarwal, Vaites, Kim, Mellert, Gurung, Nakagawa, Herlyn, Hua, Rustgi, McMahon, Diehl: "Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase." in: Cancer cell, Vol. 18, Issue 4, pp. 329-40, (2010) (PubMed).

Halilovic, She, Ye, Pagliarini, Sellers, Solit, Rosen: "PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling." in: Cancer research, Vol. 70, Issue 17, pp. 6804-14, (2010) (PubMed).

Zheng, Armes, Slavin, Zhu, Ni: "Preliminary comparison of tumor biologic factors in breast carcinomas from Australian and Chinese women." in: Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology, Vol. 32, Issue 3, pp. 155-60, (2010) (PubMed).

Satiroglu-Tufan, Dodurga, Gok, Cetinkaya, Feitelson: "RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells." in: Genetics and molecular research : GMR, Vol. 9, Issue 3, pp. 1557-67, (2010) (PubMed).

Iwatani, Fujimoto, Ito: "Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction." in: Biochemical and biophysical research communications, Vol. 400, Issue 3, pp. 426-31, (2010) (PubMed).

Target Details for Cyclin D1

Target: Cyclin D1 (CCND1)

Alternative Name: CCND1

Background: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.

Molecular Weight: 33729

NCBI Accession: NP_444284

UniProt: P24385

Pathways: PI3K-Akt Signaling, Cell Division Cycle, Mitotic G1-G1/S Phases, ER-Nucleus Signaling